Geoffrey von Maltzahn works at the frontier of generative biology, using AI to learn the rules of DNA and proteins so that entirely new medicines can be generated rather than discovered through trial-and-error, and he holds the rare dual role of both Flagship general partner and serial founding CEO of multiple companies like Tessera Therapeutics and Lila Sciences. He advocates for scientific superintelligence through AI-driven automated science factories that continuously run experiments, and he treats entrepreneurship as a trainable craft by pairing founding scientists with world-class capabilities so first-time entrepreneurs can operate at the level of mature companies. Geoffrey von Maltzahn works at the frontier of generative biology, using AI to learn the rules of DNA and proteins so that entirely new medicines can be generated rather than discovered through trial-and-error, and he holds the rare dual role of both Flagship general partner and serial founding CEO of multiple companies like Tessera Therapeutics and Lila Sciences. He advocates for scientific superintelligence through AI-driven automated science factories that continuously run experiments, and he treats entrepreneurship as a trainable craft by pairing founding scientists with world-class capabilities so first-time entrepreneurs can operate at the level of mature companies.